Ociperlimab (BGB-A1217) is a humanized antibody targeting TIGIT with antitumor activity. It blocks the TIGIT-PVR interaction and is used in the study of advanced solid tumors.
Purity:
99.17%
CAS Number:
[2342597-93-5]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted